Jump to content

Drilldown: Medicines

Choose a table:


Medicines > classes : Antipsychotic or Nootropic or Phenethylamine

Use the filters below to narrow your results.

generic:
brand:
None (38) · Compazine (1) · Fanapt (1) · Geodon (1) · Inapsine (1) · Invega (1) · Latuda (1) · Loxitane (1) · Mellaril (1) · Moban (1) · Navane (1) · Nexus, Eroxan (historical, late-1980s through mid-1990s) (1) · Orap (1) · Prolixin (1) · Saphris (1) · Stelazine (1) · Thorazine (1) · Trilafon (1)
classes: (Click arrow to add another value)
mechanism:
5-HT2A agonist (12) · 5-HT2A agonist; long duration (1) · 5-HT2A agonist; MAO inhibitor (1) · 5-HT2A agonist; milder than other 2C-x (1) · 5-HT2A partial agonist (1) · ACTH analogue; BDNF upregulator (1) · AMPA modulator; catecholaminergic (1) · AMPA receptor modulator (1) · AMPA receptor positive allosteric modulator (2) · AMPA/NMDA modulator; NGF/BDNF upregulation (1) · Butyrophenone D2 antagonist (1) · D2 receptor antagonist; also H1, alpha-1, muscarinic antagonist (1) · D2/5-HT2A antagonist (1) · D2/5-HT2A antagonist; 5-HT7 antagonist (1) · D2/5-HT2A antagonist; active metabolite of risperidone (1) · D2/5-HT2A antagonist; SRI and NRI (1) · Dibenzoxazepine D2/5-HT2 antagonist (1) · Dihydroindolone D2 antagonist (1) · Diphenylbutylpiperidine D2 antagonist (1) · Dopamine and serotonin reuptake inhibitor; actoprotector (1) · Extremely potent 5-HT2A agonist; vasoconstrictor (1) · Extremely potent 5-HT2A agonist; very long duration (1) · GABAB agonist; alpha-2-delta calcium channel ligand (1) · Glutamate receptor antagonist; GABA modulator (1) · High-affinity choline uptake enhancer (2) · Multi-receptor antagonist (D2, 5-HT2A, H1, alpha) (1) · Phenothiazine D2 antagonist (5) · Potent 5-HT2A agonist (5) · Potent 5-HT2A agonist; no oral activity (1) · Potent 5-HT2A agonist; very long duration (1) · Prodrug of modafinil (1) · Serotonin precursor; 5-hydroxytryptophan (1) · Thioxanthene D2 antagonist (1) · Very potent 5-HT2A agonist; long duration (1)
uses:
None (55)
starting dose:
None (55)
preparations:
None (55)
fda max:
None (55)
routes:
None (54) · insufflated (1) · Oral (1) · PR (1)
onset:
None (54) · 45-75 min (oral) (1)
duration:
None (54) · 4-8 h (1)
halflife:
None (54) · Not well characterized (1)
bioavailability:
None (54) · Not well characterized (1)
pregnancy:
None (54) · Not established (1)
legal:
None (54) · [[USLegal:DEA Schedule I|Schedule I]] (United States) (1)

Showing below up to 55 results in range #1 to #55.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"